Inpatient dermatologic consultations require expert care to make a prompt and accurate diagnosis. For best practices, Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Olayemi Sokumbi, a dermatologist and dermatopathologist with Mayo Clinic. Watch as Dr. Sokumbi shares the three categories you need to consider in your initial exam of an inpatient. Hear why a close partnership with a dermatopathologist can help in making an accurate diagnosis. Learn signs for when you may need to revisit your diagnosis. Plus Dr. Sokumbi outlines why infections are important to consider especially in immunocompromised patients.
Further Reading
If you want to read more about dermatologic conditions that may present in inpatients, check out the following articles published in the Journal of Drugs in Dermatology:
ABSTRACT
Introduction: Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is a rare and dangerous dermatologic emergency. It can have different presentations, especially in patients with multiple drug causes, and definitive management of SJS/TEN in these presentations remains unclear. Systemic corticosteroids, TNF inhibitors, and cyclosporine A are promising therapies.
Case Report: In this case report, we present a 55-year-old man who developed SJS/TEN while on pembrolizumab and lamotrigine. The patient was treated with corticosteroids and a single dose of etanercept. After a one-week follow-up, the patient’s SJS/TEN had no new activity.
Discussion: This literature review highlights how SJS/TEN may present differently in patients on immune checkpoint inhibitors. Treatments in these cases may vary from those with classic SJS/TEN. Specifically, etanercept given days late into the disease course is effective in speeding re-epithelialization and tapering of already given corticosteroids in classic SJS/TEN.
Cutaneous Sarcoidosis in Skin of Color
ABSTRACT
Cutaneous sarcoidosis presents in 25% of all sarcoidosis cases. African American populations, particularly African American women, are more likely to develop the dermatologic manifestations of the disease. There are several types of skin manifestations of sarcoidosis, which can make it more difficult to diagnose it clinically. Given the higher incidence of sarcoidosis and the poorer outcomes in these populations, it is essential to understand and recognize the variety of dermatologic symptoms associated with sarcoidosis. By doing so, patients can be diagnosed and treated earlier in their disease progression.
Did you enjoy this video interview? Find more here.
